DIA Biosimilars 2013

Articles Published in 2010

Parexel Releases eClinical Platform for Late-Stage Clinical Trials

Tuesday, April 13, 2010 07:26 AM

Parexel, a CRO, released a new web-based platform to be used in late-phase clinical research to help users meet regulatory guidelines and ensure high quality data. The new product combines the expertise of Parexel’s existing Peri Approval Clinical Excellence (PACE) team with the eClinical capabilities of Perceptive Informatics, Parexel’s technology subsidiary. The platform allows for a variety of eClinical services, such as clinical trial management systems, electronic data capture, randomization and trial supply management, and electronic patient-reported outcomes, to be incorporated in late-phase studies.

More... »

Cenduit: Now with Patient Reminders

Clinical Research Advantage Expanding to Las Vegas, Omaha

Monday, April 12, 2010 07:12 AM

After 20 years of business, site management organization (SMO) Clinical Research Advantage (CRA) is expanding beyond its home base of Phoenix buying five sites in Las Vegas and plans to open a site in Omaha, Neb.

More... »

CRF Health – eCOA Forum

Guest Commentary: Risk-Share Models in Patient Recruitment--An Insider's View of Metrics and Payment Markers

Friday, April 9, 2010 08:24 AM

By Melynda Geurts and Carl T. Wibbenmeyer

More... »

CenterWatch Monthly April 2010

Thursday, April 8, 2010 07:52 AM

What’s in a Name? Site Groups in the Post-SMO Era

More... »

Medpace Buys Medical Device CRO Symbios

Wednesday, April 7, 2010 01:55 PM

Cincinnati-based contract research organization (CRO) Medpace acquired medical device CRO Symbios for an undisclosed amount. Symbios was advised by Fairmount Partners in this transaction.

More... »

i3 Takes on PRO Measurement with QualityMetric Deal

Wednesday, April 7, 2010 07:00 AM

Ingenix, the parent company of pharmaceutical services company i3, added patient-reported outcomes (PRO) services to its portfolio with the recent acquisition of QualityMetric for an undisclosed amount.

More... »

ICON Opens Office in Philippines

Tuesday, April 6, 2010 06:59 AM

Dublin, Ireland-based contract research organization (CRO) ICON opened an office in Manila, Philippines, to support the company’s growth in Asia-Pacific.

More... »

BioClinica Buys TranSenda, Adds CTMS to Service Offerings

Monday, April 5, 2010 06:52 AM

BioClinica continued to grow its burgeoning eClinical division with the acquisition of clinical trial management software (CTMS) company TranSenda for an estimated $2.5 million.

More... »

Total AAHRPP-Accredited Organizations Tops 200

Wednesday, March 31, 2010 06:54 AM

The Association for the Accreditation of Human Research Protection Programs (AAHRPP) accredited six additional organizations, bringing the total number of AAHRPP-accredited organizations above 200. The latest accreditation recipients included three universities, two independent IRBs, and a teaching hospital system.

More... »

New Worldwide Executive Director Shares DIA’s Vision at EuroMeeting

Tuesday, March 30, 2010 06:56 AM

With a new worldwide executive director and vision, the Drug Information Association (DIA) has grand plans for 2010 and beyond.

More... »

`
CenterWatch Drugs in Clinical Trials Database Library. Drug intelligence right at your fingertips.
CLINICAL TRIAL RESOURCES

Search:

NEWS ONLINE ARCHIVE

Browse by:

CWWeekly

September 30

Novartis-Walgreens pilot study blurring the line between retail pharmacy, investigative site

CISCRP to launch traveling science museum exhibit to demystify clinical trial participation

Already a subscriber?
Log in to your digital subscription.

Subscribe to CWWeekly.

The CenterWatch Monthly

October

New growth and decline in Asia clinical trials
South Korea, Japan, China see big growth in 1572s, while India posts huge drop

Harnessing Big Data to transform clinical trials
From protocol to patient recruiting, data analytics can yield valuable insights

Already a subscriber?
Log in to your digital subscription.

Purchase the October issue.

Subscribe to
The CenterWatch Monthly.

The CenterWatch Monthly

September

Sponsors look to collaborate on comparator drugs
Co-therapies, comparators are in 60% of studies, cost $25m per company a year

Early adopters implement risk-based monitoring pilot programs
Experiments aim to offer long-term solutions, despite short-term uncertainties

Already a subscriber?
Log in to your digital subscription.

Purchase the September issue.

Subscribe to
The CenterWatch Monthly.

JobWatch centerwatch.com/jobwatch

Featured Jobs